zidovudine has been researched along with Urinary Bladder Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braga, AL; Campos, VF; Collares, T; da Silva, RS; de Souza, D; Dornelles, L; Ilha, V; Mariano, DO; Munchen, TS; Nedel, F; Rocha, JB; Rodrigues, OE; Schultze, E; Seixas, F | 1 |
| Erlichman, C; Mitrovski, B; Pressacco, J | 1 |
2 other study(ies) available for zidovudine and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
New organochalcogen multitarget drug: synthesis and antioxidant and antitumoral activities of chalcogenozidovudine derivatives.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Line, Tumor; Chalcogens; Humans; Male; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Urinary Bladder; Urinary Bladder Neoplasms; Zidovudine | 2015 |
Cytotoxic and biochemical implications of combining AZT and AG-331.
Topics: Antimetabolites, Antineoplastic; Cell Division; DNA Damage; DNA-Directed DNA Polymerase; DNA, Single-Stranded; Drug Interactions; Drug Synergism; Humans; Image Processing, Computer-Assisted; Indoles; Substrate Specificity; Thymidylate Synthase; Thymine Nucleotides; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Zidovudine | 1995 |